Golden Biotechnology Corporation (TPEX:4132)
Taiwan · Delayed Price · Currency is TWD 23.00
+3.15 (15.87%)
At close: Dec 5, 2025
Golden Biotechnology Market Cap
Golden Biotechnology has a market cap or net worth of 3.73 billion as of December 5, 2025. Its market cap has increased by 29.21% in one year.
Market Cap
3.73B
Enterprise Value
4.00B
Revenue
44.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
23.00
Market Cap Chart
Since May 26, 2010, Golden Biotechnology's market cap has increased from 1.15B to 3.73B, an increase of 225.30%. That is a compound annual growth rate of 7.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 3.64B | 44.37% |
| Dec 31, 2024 | 2.52B | -54.81% |
| Dec 29, 2023 | 5.58B | -34.69% |
| Dec 30, 2022 | 8.55B | -50.08% |
| Dec 30, 2021 | 17.12B | 165.10% |
| Dec 31, 2020 | 6.46B | 66.72% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 258.22B |
| PharmaEssentia | 191.95B |
| Lotus Pharmaceutical | 78.89B |
| Bora Pharmaceuticals Co., LTD. | 65.31B |
| Oneness Biotech | 32.96B |
| Lumosa Therapeutics | 32.77B |
| Lin BioScience | 32.35B |
| Center Laboratories | 27.88B |